MSB 1.87% $1.09 mesoblast limited

what was explained to me was FDA can grant accelerated approval...

  1. 15,030 Posts.
    lightbulb Created with Sketch. 812
    what was explained to me was FDA can grant accelerated approval for CHF treatment based on its overwhelming benefits of reducing mortality and its reduction of inflammation marker around the aorta tissue. CHF and LB treatments look very positive, So goes GVHD however a jump through hoop trial will be required, however I'm optimistic we will prevail.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
0.020(1.87%)
Mkt cap ! $1.238B
Open High Low Value Volume
$1.11 $1.12 $1.08 $7.968M 7.258M

Buyers (Bids)

No. Vol. Price($)
15 155863 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.09 50009 15
View Market Depth
Last trade - 13.16pm 03/05/2024 (20 minute delay) ?
Last
$1.09
  Change
0.020 ( 1.85 %)
Open High Low Volume
$1.10 $1.12 $1.08 1257574
Last updated 13.35pm 03/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.